Advances in Cancer Immunotherapy™: A Focus on Cellular Therapies and T Cell Engagers

When:  Dec 18, 2021 from 08:00 to 12:00 (CT)
This program will be hosted virtually.


Sairah Ahmed, MD – The University of Texas MD Anderson Cancer Center
Umar Farooq, MD University of Iowa
Armin Ghobadi, MD Washington University School of Medicine
Yi Lin, MD, PhD
Mayo Clinic

Program Learning Objectives

  • Describe the mechanisms of cell therapies and T cell engagers.
  • Summarize recent updates in the use of cell therapies and T cell engagers clinically and toxicity management for key disease states.
  • Outline common toxicities with cell therapies and T cell engagers and their management.
  • Identify unique institutional resources required for the appropriate use of cell therapies.

    For more information on the program, click below.


    View the SITC Meeting Code of Conduct.